XML 14 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Balance Sheets - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash $ 30,102,144 $ 32,898,676
Short-term investments 12,009,000 15,012,225
Accounts receivable 7,976,760 7,952,478
Inventories 5,270,049 5,724,397
Deferred costs 2,049,330 1,199,217
Prepaid expenses and other current assets 3,178,256 3,274,254
Total current assets 60,585,539 66,061,247
Equipment, molds, furniture and fixtures, net 17,142,571 14,793,084
Patent rights, net 2,331,347 2,434,542
Goodwill 1,095,355 1,095,355
Other assets 153,826 177,943
Total Assets 81,308,638 84,562,171
Current Liabilities:    
Accounts payable 6,960,444 5,187,703
Accrued expenses and other liabilities 8,530,420 6,488,032
Deferred revenue 5,254,028 5,143,825
Total current liabilities 20,744,892 16,819,560
Deferred revenue – long term 680,600 700,000
Total liabilities $ 21,425,492 $ 17,519,560
Stockholders’ Equity:    
Preferred Stock: $0.01 par, authorized 3,000,000 shares, none outstanding
Common Stock: $0.01 par; authorized 200,000,000 shares; 154,927,660 and 154,848,512 issued and outstanding at March 31, 2016 and December 31, 2015, respectively $ 1,549,277 $ 1,548,485
Additional paid-in capital 295,792,964 295,292,414
Accumulated deficit (236,762,612) (229,106,502)
Accumulated other comprehensive loss (696,483) (691,786)
Total Stockholders' Equity 59,883,146 67,042,611
Total Liabilities and Stockholders’ Equity $ 81,308,638 $ 84,562,171